BioSyent, Inc. (RX.V)
12.05
+0.23
(+1.95%)
CAD |
TSXV |
Dec 11, 16:00
BioSyent Shareholders Equity (Quarterly): 39.90M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biocure Technology, Inc. | 1.604M |
| Core One Labs, Inc. | -- |
| Restart Life Sciences Corp. | -0.1483M |
| NanoSphere Health Sciences, Inc. | -1.909M |
| Lobe Sciences Ltd. | 3.560M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 47.79M |
| Total Liabilities (Quarterly) | 7.882M |
| Debt to Equity Ratio | 0.0224 |
| Current Ratio | 5.061 |
| Net Debt Paydown Yield | 0.04% |